Quick Answer
Minerva Neurosciences, Inc. reported Operating Income Loss of -$15.10 million for the year ending 2025.
- Minerva Neurosciences, Inc. showed an increase of +30.9% in Operating Income Loss from 2024 to 2025.
- This data is from Minerva Neurosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), Minerva Neurosciences, Inc.'s Operating Income Loss has declined by 375.7%.
- Historical annual values: Fiscal year 2025: -$15.10 million | Fiscal year 2024: -$21.85 million | Fiscal year 2023: -$23.12 million | Fiscal year 2022: -$25.23 million | Fiscal year 2021: -$45.37 million | Fiscal year 2020: $1.85 million | Fiscal year 2019: -$75.87 million | Fiscal year 2018: -$51.73 million | Fiscal year 2017: -$41.17 million | Fiscal year 2016: -$30.19 million | Fiscal year 2015: -$26.11 million | Fiscal year 2014: -$54.87 million | Fiscal year 2013: -$3.17 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: